Primary Analysis and 4-Year Follow-Up of the Phase III NIBIT-M2 Trial in Melanoma Patients With Brain Metastases.

Anna Maria Di GiacomoVanna Chiarion SileniMichele Del VecchioPier Francesco FerrucciMichele GuidaPietro QuaglinoMassimo GuidoboniMarina Chiara GarassinoOrnella CutaiaGiovanni AmatoAlessia CovreRoberto CameriniLuana CalabròMonica ValenteDiana GiannarelliMario MandalàMichele Maio

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)

Compared with fotemustine, ipilimumab plus nivolumab significantly improved overall and long-term survival of patients with melanoma with asymptomatic brain metastases.

Keyphrases

brain metastases
phase iii
small cell lung cancer
open label
clinical trial
phase ii
double blind
placebo controlled
skin cancer
study protocol
randomized controlled trial
basal cell carcinoma